DE60139339D1 - Stabilisierte interferonzusammensetzungen - Google Patents
Stabilisierte interferonzusammensetzungenInfo
- Publication number
- DE60139339D1 DE60139339D1 DE60139339T DE60139339T DE60139339D1 DE 60139339 D1 DE60139339 D1 DE 60139339D1 DE 60139339 T DE60139339 T DE 60139339T DE 60139339 T DE60139339 T DE 60139339T DE 60139339 D1 DE60139339 D1 DE 60139339D1
- Authority
- DE
- Germany
- Prior art keywords
- interferon compositions
- stabilized interferon
- stabilized
- compositions
- interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24645600P | 2000-11-07 | 2000-11-07 | |
US25222400P | 2000-11-21 | 2000-11-21 | |
PCT/US2001/047514 WO2002038170A2 (en) | 2000-11-07 | 2001-11-07 | Stabilized inteferon compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60139339D1 true DE60139339D1 (de) | 2009-09-03 |
Family
ID=26937990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60139339T Expired - Lifetime DE60139339D1 (de) | 2000-11-07 | 2001-11-07 | Stabilisierte interferonzusammensetzungen |
Country Status (16)
Country | Link |
---|---|
US (2) | US6994847B2 (de) |
EP (1) | EP1343518B1 (de) |
JP (2) | JP4129178B2 (de) |
CN (1) | CN1330372C (de) |
AU (2) | AU3070702A (de) |
BG (1) | BG66082B1 (de) |
CA (1) | CA2428144C (de) |
CZ (1) | CZ20031259A3 (de) |
DE (1) | DE60139339D1 (de) |
ES (1) | ES2330508T3 (de) |
HU (1) | HU228583B1 (de) |
IL (2) | IL155788A0 (de) |
NO (1) | NO330690B1 (de) |
PL (1) | PL209928B1 (de) |
PT (1) | PT1343518E (de) |
WO (1) | WO2002038170A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040002451A1 (en) | 2002-06-20 | 2004-01-01 | Bruce Kerwin | Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
WO2005011605A2 (en) * | 2003-08-01 | 2005-02-10 | Medarex, Inc. | Combination therapies for multiple sclerosis |
JP5385529B2 (ja) * | 2004-04-22 | 2014-01-08 | ハイランド インダストリーズ,インコーポレーテッド | スペーサファブリック |
US7276275B2 (en) * | 2004-04-22 | 2007-10-02 | Highland Industries, Inc. | Laminated spacer fabric |
WO2006125207A2 (en) | 2005-05-19 | 2006-11-23 | Amgen Inc. | Compositions and methods for increasing the stability of antibodies |
WO2006136302A1 (de) * | 2005-06-21 | 2006-12-28 | Merck Patent Gmbh | Feste pharmazeutische zubereitung enthaltend (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
ES2925992T3 (es) | 2006-10-20 | 2022-10-20 | Amgen Inc | Formulaciones estables de polipéptidos |
CN101190329B (zh) * | 2006-11-29 | 2013-03-06 | 信谊药厂 | 一种重组人p43蛋白的药物组合物及其在医药上的应用 |
WO2008137471A2 (en) | 2007-05-02 | 2008-11-13 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
JP2011195557A (ja) * | 2010-02-24 | 2011-10-06 | Kyorin Pharmaceutical Co Ltd | 糖アルコールの選択方法 |
EP2542574B1 (de) | 2010-03-04 | 2017-08-09 | Pfenex Inc. | Verfahren zur herstellung eines löslichen und rekombinanten interferonproteins ohne denaturierung |
CN102585011A (zh) * | 2012-02-10 | 2012-07-18 | 中国农业大学 | 一种犬α干扰素衍生物的制备方法与应用 |
AU2015335743B2 (en) | 2014-10-23 | 2020-12-24 | Amgen Inc. | Reducing viscosity of pharmaceutical formulations |
JP7377596B2 (ja) | 2017-02-22 | 2023-11-10 | アムジエン・インコーポレーテツド | 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法 |
US10799639B2 (en) * | 2017-03-03 | 2020-10-13 | Min Wei | Syringe type medication delivery device |
CN113797318B (zh) * | 2021-10-26 | 2023-06-30 | 深圳科兴药业有限公司 | 一种干扰素组合物及其制备方法和应用 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439181A (en) | 1981-01-26 | 1984-03-27 | Regents Of The University Of Minnesota | Polyol-hormone mixture for use in chronic parenteral hormone administration |
JPS5821691A (ja) | 1981-07-29 | 1983-02-08 | Mochida Pharmaceut Co Ltd | α−及びβ−インタ−フェロンの精製方法 |
EP0080879B1 (de) | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung |
AU1234383A (en) | 1982-03-17 | 1983-09-22 | Inter-Yeda Ltd. | Interferon stabilised with polyvinyl-pyrrolidone |
US4992271A (en) | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
US4462940A (en) | 1982-09-23 | 1984-07-31 | Cetus Corporation | Process for the recovery of human β-interferon-like polypeptides |
US5702699A (en) | 1982-09-23 | 1997-12-30 | Cetus Corporation | Process for the recovery of lipophilic proteins |
US5643566A (en) | 1982-09-23 | 1997-07-01 | Cetus Corporation | Formulation processes for lipophilic proteins |
DE3484374D1 (de) | 1983-08-04 | 1991-05-08 | Green Cross Corp | Gamma-interferonzusammensetzung. |
JPS6069037A (ja) | 1983-09-26 | 1985-04-19 | Sunstar Inc | エリテマト−デス治療用外用剤 |
WO1985002118A1 (en) | 1983-11-21 | 1985-05-23 | Regents Of The University Of Minnesota | A buffered polyol-hormone mixture for use in chronic parenteral hormone administration |
US4605555A (en) | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
US4816440A (en) | 1985-09-26 | 1989-03-28 | Cetus Corporation | Stable formulation of biologically active proteins for parenteral injection |
US5183746A (en) | 1986-10-27 | 1993-02-02 | Schering Aktiengesellschaft | Formulation processes for pharmaceutical compositions of recombinant β- |
CA1294215C (en) | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
US4808705A (en) * | 1986-12-19 | 1989-02-28 | Cetus Corporation | Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor |
US4894330A (en) * | 1986-12-23 | 1990-01-16 | Cetus Corporation | Purification of recombinant beta-interferon incorporating RP-HPLC |
EP0284249A1 (de) * | 1987-03-13 | 1988-09-28 | Interferon Sciences, Inc. | Gefriergetrocknete Lymphokin-Zusammensetzung |
IT1222427B (it) * | 1987-07-31 | 1990-09-05 | Sclavo Spa | Procedimento per la purificazione di interferone |
US5151265A (en) | 1987-11-03 | 1992-09-29 | Genentech, Inc. | Gamma interferon formulation |
US5004605A (en) | 1987-12-10 | 1991-04-02 | Cetus Corporation | Low pH pharmaceutical compositions of recombinant β-interferon |
US5104651A (en) | 1988-12-16 | 1992-04-14 | Amgen Inc. | Stabilized hydrophobic protein formulations of g-csf |
IL89662A (en) * | 1989-03-19 | 1997-11-20 | Interpharm Lab Ltd Kiryat Weiz | Pharmaceutical compositions comprising interferon-beta |
ATE148165T1 (de) | 1989-07-24 | 1997-02-15 | Bayer Ag | Stabilisierung von hochgereinigten proteinen |
JPH05963A (ja) * | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
TW249202B (de) | 1993-08-13 | 1995-06-11 | Ciba Gerigy Corp | |
FR2710637B1 (fr) | 1993-09-28 | 1995-12-08 | Roquette Freres | Mannitol pulvérulent de friabilité modérée et son procédé de préparation. |
FR2719479B1 (fr) | 1994-05-04 | 1996-07-26 | Sanofi Elf | Formulation stable lyophilisée comprenant une protéine: kit de dosage. |
US5542303A (en) * | 1994-05-12 | 1996-08-06 | Neuffer; A. Erich | Dual-peak torque measuring apparatus |
IT1272252B (it) | 1994-05-16 | 1997-06-16 | Applied Research Systems | Formulazioni liquide di interferone beta |
ATE299892T1 (de) | 1994-05-18 | 2005-08-15 | Nektar Therapeutics | Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen |
JP2758154B2 (ja) | 1995-04-06 | 1998-05-28 | エフ・ホフマン−ラ ロシユ アーゲー | インターフェロンを含む液体製剤 |
EP0875253B1 (de) * | 1997-05-02 | 2005-04-06 | Seikagaku Corporation | Chondroitinase enthaltende Zusammensetzungen |
US6887462B2 (en) * | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
-
2001
- 2001-11-07 CN CNB018206980A patent/CN1330372C/zh not_active Expired - Lifetime
- 2001-11-07 AU AU3070702A patent/AU3070702A/xx active Pending
- 2001-11-07 PL PL366329A patent/PL209928B1/pl unknown
- 2001-11-07 JP JP2002540752A patent/JP4129178B2/ja not_active Expired - Lifetime
- 2001-11-07 DE DE60139339T patent/DE60139339D1/de not_active Expired - Lifetime
- 2001-11-07 CZ CZ20031259A patent/CZ20031259A3/cs unknown
- 2001-11-07 ES ES01990949T patent/ES2330508T3/es not_active Expired - Lifetime
- 2001-11-07 IL IL15578801A patent/IL155788A0/xx unknown
- 2001-11-07 CA CA2428144A patent/CA2428144C/en not_active Expired - Lifetime
- 2001-11-07 PT PT01990949T patent/PT1343518E/pt unknown
- 2001-11-07 EP EP01990949A patent/EP1343518B1/de not_active Expired - Lifetime
- 2001-11-07 US US10/010,448 patent/US6994847B2/en not_active Expired - Lifetime
- 2001-11-07 HU HU0301653A patent/HU228583B1/hu unknown
- 2001-11-07 WO PCT/US2001/047514 patent/WO2002038170A2/en active Application Filing
- 2001-11-07 AU AU2002230707A patent/AU2002230707B2/en not_active Expired
-
2003
- 2003-05-06 IL IL155788A patent/IL155788A/en active IP Right Grant
- 2003-05-06 NO NO20032033A patent/NO330690B1/no not_active IP Right Cessation
- 2003-06-06 BG BG107887A patent/BG66082B1/bg unknown
-
2005
- 2005-07-22 US US11/188,257 patent/US7662369B2/en not_active Expired - Lifetime
-
2007
- 2007-10-25 JP JP2007278231A patent/JP2008069171A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PL366329A1 (en) | 2005-01-24 |
PL209928B1 (pl) | 2011-11-30 |
BG66082B1 (bg) | 2011-03-31 |
CZ20031259A3 (cs) | 2004-01-14 |
CN1481252A (zh) | 2004-03-10 |
NO20032033D0 (no) | 2003-05-06 |
HUP0301653A2 (en) | 2007-02-28 |
WO2002038170A2 (en) | 2002-05-16 |
EP1343518A2 (de) | 2003-09-17 |
AU2002230707B2 (en) | 2006-08-24 |
BG107887A (bg) | 2004-01-30 |
CA2428144C (en) | 2012-01-10 |
CA2428144A1 (en) | 2002-05-16 |
JP4129178B2 (ja) | 2008-08-06 |
EP1343518B1 (de) | 2009-07-22 |
AU3070702A (en) | 2002-05-21 |
US20020114782A1 (en) | 2002-08-22 |
ES2330508T3 (es) | 2009-12-11 |
CN1330372C (zh) | 2007-08-08 |
HU228583B1 (en) | 2013-04-29 |
US7662369B2 (en) | 2010-02-16 |
JP2004536021A (ja) | 2004-12-02 |
IL155788A (en) | 2013-09-30 |
NO330690B1 (no) | 2011-06-14 |
NO20032033L (no) | 2003-07-03 |
PT1343518E (pt) | 2009-08-03 |
IL155788A0 (en) | 2003-12-23 |
WO2002038170A3 (en) | 2003-03-27 |
US6994847B2 (en) | 2006-02-07 |
US20060008447A1 (en) | 2006-01-12 |
HUP0301653A3 (en) | 2009-03-30 |
JP2008069171A (ja) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE303787T1 (de) | Schergelzusammensetzungen | |
DE60142412D1 (de) | Stabilisiertes interleukin 2 | |
IS2932B (is) | Fúlvestrant samsetning | |
FI20010780A0 (fi) | Parannetut koostumukset | |
AR028197A1 (es) | Composiciones antitranspirantes | |
DE60118496D1 (de) | Pulverzusammensetzung | |
FI20105657A (fi) | Farmaseuttisia koostumuksia | |
AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
ITMI20010748A0 (it) | Composizioni farmaceutiche | |
IS6915A (is) | Lyfjablanda | |
BR0210619A (pt) | composição | |
IS7081A (is) | Lyfjablanda | |
ATE369830T1 (de) | Schweisshemmende zusammensetzungen | |
DE60139339D1 (de) | Stabilisierte interferonzusammensetzungen | |
ATE314049T1 (de) | Schweisshemmende zusammensetzungen | |
NO20026123L (no) | Farmasöytiske sammensetninger | |
DE60116858D1 (de) | Zusammensetzung | |
NO20031095L (no) | Farmasoytiske sammensetninger | |
DE60103292D1 (de) | Fungizide zusammensetzungen | |
DE60104098D1 (de) | Brennstoffzusammensetzung | |
NO20020524D0 (no) | Stabiliserte organisk-peroksid sammensetninger | |
ITTO20020744A0 (it) | Composizione | |
DE60107312D1 (de) | Feste Zusammensetzung | |
DE60135223D1 (de) | Shampoozusammensetzungen | |
ITTO20020745A0 (it) | Composizione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |